Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival

Molecular and Clinical Oncology
Duygu Ucar, Douglas I Lin

Abstract

High-grade serous carcinoma (HGSC) of the ovary is an aggressive and devastating neoplasm and the identification of novel therapeutic targets may result in a significant decrease in patient morbidity and mortality. Over the last few years, chromatin regulators have become attractive targets for cancer therapy. More specifically, bromodomain-containing protein 4 (BRD4), a protein that is associated with acetylated chromatin and transcriptional activation, has been shown to selectively regulate the transcription of key oncogenic drivers, such as CMYC, in several tumor types. The Cancer Genome Atlas (TCGA) Project has molecularly characterized the genome of ovarian serous carcinomas, which enabled us to study the association of genomic alterations of BRD4 with patient survival and clinicopathological characteristics. Our analysis using clinical and genomic data from the TCGA ovarian carcinoma samples revealed that somatic amplification of BRD4 (observed in 12% of the cases) was correlated with increased BRD4 mRNA levels and is significantly associated with worse overall and progression-free survival compared to wild-type cases. These findings support the hypothesis that future studies and trials investigating newly developed BRD4 ...Continue Reading

References

May 23, 2009·Nature Reviews. Cancer·Robert C BastGordon B Mills
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 5, 2011·Nature·Johannes ZuberChristopher R Vakoc
Sep 6, 2011·Cell·Jake E DelmoreConstantine S Mitsiades
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jennifer A MertzRobert J Sims
Feb 23, 2013·Cancer Discovery·Alexandre PuissantKimberly Stegmaier
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Sep 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dariush EtemadmoghadamDavid D Bowtell
Nov 29, 2013·Genes & Development·Junwei ShiChristopher R Vakoc
Jun 7, 2014·Molecular Cell·Junwei Shi, Christopher R Vakoc
Nov 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yumi Yashiro-OhtaniWarren S Pear
Dec 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Maria Giuseppina BarattaDavid M Livingston

❮ Previous
Next ❯

Citations

Nov 27, 2019·Cancers·Mudra BinjuYu Yu
Jan 21, 2021·Cellular Oncology (Dordrecht)·Angeliki AndrikopoulouFlora Zagouri
Jul 3, 2021·International Journal of Cancer. Journal International Du Cancer·Aisling Y Coughlan, Giuseppe Testa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.